Curis, Inc.
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, whic…
Biotechnology
US, Lexington [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Curis, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDCuris, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Curis, Inc..
If you want to see a demo, head over to the financial segments of AAPL